Personal profile
Education
- 2018 PhD, Graduate Institute of Clinical Medicine, College of Medicine, National Yang-Ming University
- 2003 MD, College of Medicine, National Defense Medical Center
Experience
- Director, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
- Director, Division of Gynecology, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
- Attending, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
- 2023.02- Associate Professor, Department of Obstetrics & Gynecology, School of Medicine, College of Medicine, Taipei Medical University
- Assistant Professor, Department of Obstetrics & Gynecology, School of Medicine, College of Medicine, Taipei Medical University
- 2012.05-2019.03 Attending, Department of Obstetrics & Gynecology,Taipei Veterans General Hospital
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Detection &. Risk Assessment of Ovarian Tumors by Dna Methylation Biomarkers from Cervical Swab
Wen, K.-C. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Detection &. Risk Assessment of Ovarian Tumors by Dna Methylation Biomarkers from Cervical Swab
Wen, K.-C. (PI)
8/1/24 → 7/31/27
Project: A - Government Institution › b - National Science and Technology Council
-
Discovery of New Dna Methylation Biomarkers to Improve the Performance of Self-Sampling Mpap (Mpap 2.0)
Wen, K.-C. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Discovery of New Dna Methylation Biomarkers to Improve the Performance of Self-Sampling Mpap (Mpap 2.0) (1/2)
Wen, K.-C. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Development of an Epigenetic Classification of High Grade Serous Ovarian Carcinoma (Hgsoc) Using Cancer Stem Cell Differentiation
Wen, K.-C. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
Accuracy of HPV Testing Using Self-collected Urine Compared With Physician-collected Cervical Specimen for HSIL or Worse
Chen, C. C., Hsiao, K. Y., Lu, S. C., Bai, C. H., Wen, K. C. & Wang, Y. H., 2026, In: Journal of Lower Genital Tract Disease. 30, 2, p. 100-109 10 p.Research output: Contribution to journal › Article › peer-review
-
Programmed death-ligand 1 upregulation is associated with poor prognosis in patients with epithelial ovarian cancer
Liu, C. H., Chao, W. T., Yang, S. T., Lin, C. H., Wen, K. C. & Wang, P. H., 2026, In: Journal of the Chinese Medical Association. 89, 1, p. 25-34 10 p.Research output: Contribution to journal › Article › peer-review
Open Access15 Link opens in a new tab Citations (Scopus) -
A DNA methylation assay (MPap) using self-collected tampon versus cytology collection swab for endometrial cancer detection
Su, K. M., Wen, K. C., Lin, Y. H., Su, P. H., Chen, L. Y. & Lai, H. C., 2025, In: International Journal of Gynecology and Obstetrics. 173, 3, p. 1400-1407 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Combined pembrolizumab and bevacizumab therapy in heavily treated recurrent ovarian cancer
Wang, S.-Y., Chou, Y. T., Wen, K.-C., Liew, P.-L., Lu, Y.-H., Chen, L.-Y., Sung, P. L., Lai, H.-C. & Chu, L.-H., Aug 2025, In: European Journal of Gynaecological Oncology. 46, 8, p. 48Research output: Contribution to journal › Article › peer-review
-
Exploring potential methylation markers for ovarian cancer from cervical scraping samples
Lien, J. Y., Hii, L. A., Su, P. H., Chen, L. Y., Wen, K. C., Lai, H. C. & Wang, Y. C., Dec 2025, In: Human Genomics. 19, 1, 56.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Citations (Scopus)
Datasets
-
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5234313.v1, https://springernature.figshare.com/collections/Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/5234313/1
Dataset
-
Additional file 1 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Chou, P.-C. (Contributor), Wu, A. T. H. (Creator), Sung, P.-L. (Contributor), Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Yeung, S.-C. J. (Contributor) & Lee, M.-H. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.12845522.v1, https://doi.org/10.6084%2Fm9.figshare.12845522.v1
Dataset
-
Additional file 3 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor), Wu, A. T. H. (Creator), Sung, P.-L. (Contributor), Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor) & Wen, K.-C. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12845528.v1, https://doi.org/10.6084%2Fm9.figshare.12845528.v1
Dataset
-
Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.13352142.v1, https://springernature.figshare.com/articles/figure/Additional_file_1_of_Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/13352142/1
Dataset
-
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Huang, C.-Y. F. (Contributor), Sung, P.-L. (Contributor) & Wu, A. T. H. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5099513.v1, https://doi.org/10.6084%2Fm9.figshare.c.5099513.v1
Dataset